Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
| In millions, except per share items | Jul-31-14 | Jul-31-13 | Jul-31-12 | Jul-31-11 | Jul-31-10 | Jul-31-09 | Jul-31-08 | Jul-31-07 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| Euro Zone | 1,804.0 | 1,706.0 | 1,715.0 | 1,646.0 | 631.0 | 672.0 | | |
| Life Sciences | 1,453.7 | 1,309.4 | 1,253.6 | 1,184.1 | 1,021.6 | 1,166.3 | | |
| Industrial | 1,335.5 | 1,338.7 | 1,418.1 | 1,333.1 | 1,164.1 | 1,162.9 | | |
| Europe | 1,140.4 | 1,034.5 | 1,023.0 | 995.5 | 889.2 | 960.3 | | |
| Total revenues | 2,789.1 | 2,648.1 | 2,671.7 | 2,517.2 | 2,185.7 | 2,329.2 | 2,571.6 | 2,249.9 |
| Revenue growth [+] | 5.3% | -0.9% | 6.1% | 15.2% | -6.2% | -9.4% | 14.3% | 11.6% |
| Euro Zone | 5.7% | -0.5% | 4.2% | 160.9% | -6.1% | | | |
| Life Sciences | 11.0% | 4.4% | 5.9% | 15.9% | -12.4% | | | |
| Industrial | -0.2% | -5.6% | 6.4% | 14.5% | 0.1% | | | |
| Europe | 10.2% | 1.1% | 2.8% | 12.0% | -7.4% | | | |
| Asia | -0.6% | -5.5% | 9.0% | 15.7% | 7.0% | | | |
| Cost of goods sold | 1,363.0 | 1,276.1 | 1,291.6 | 1,232.3 | 1,064.1 | 1,228.5 | 1,360.8 | 1,190.5 |
| Gross profit | 1,426.2 | 1,372.0 | 1,380.1 | 1,284.9 | 1,121.5 | 1,100.7 | 1,210.8 | 1,059.4 |
| Gross margin | 51.1% | 51.8% | 51.7% | 51.0% | 51.3% | 47.3% | 47.1% | 47.1% |
| Selling, general and administrative | 814.5 | 810.4 | 843.2 | 790.3 | 716.7 | 699.8 | 749.5 | 675.0 |
| Research and development | 102.6 | 94.2 | 82.9 | 80.5 | 68.8 | 71.2 | 71.6 | 62.4 |
| Other operating expenses | 0.0 | 2.2 | 0.6 | 1.8 | -35.3 | -88.9 | -31.5 | -22.4 |
| EBITDA [+] | 625.5 | 571.5 | 564.5 | 510.5 | 465.1 | 508.0 | 514.4 | 438.3 |
| EBITDA growth | 9.4% | 1.3% | 10.6% | 9.8% | -8.5% | -1.2% | 17.4% | 23.9% |
| EBITDA margin | 22.4% | 21.6% | 21.1% | 20.3% | 21.3% | 21.8% | 20.0% | 19.5% |
| Depreciation | 95.2 | 86.4 | 90.6 | 84.7 | 82.1 | 79.7 | 93.2 | 94.0 |
| EBITA | 530.3 | 485.1 | 473.9 | 425.8 | 383.0 | 428.3 | 421.2 | 344.3 |
| EBITA margin | 19.0% | 18.3% | 17.7% | 16.9% | 17.5% | 18.4% | 16.4% | 15.3% |
| Amortization of intangibles | 21.2 | 19.9 | 20.5 | 13.4 | 11.5 | 9.8 | | |
| EBIT [+] | 509.1 | 465.3 | 453.4 | 412.4 | 371.4 | 418.6 | 421.2 | 344.3 |
| EBIT growth | 9.4% | 2.6% | 9.9% | 11.0% | -11.3% | -0.6% | 22.3% | 33.4% |
| EBIT margin | 18.3% | 17.6% | 17.0% | 16.4% | 17.0% | 18.0% | 16.4% | 15.3% |
| Non-recurring items [+] | 40.1 | 38.0 | 66.3 | 24.7 | 35.3 | 32.5 | 31.5 | 22.4 |
| Asset impairment | | | | | 17.7 | 30.7 | | |
| Interest expense, net [+] | 8.5 | 7.2 | 11.7 | 11.8 | 8.7 | 19.4 | 32.6 | 39.1 |
| Interest expense | 17.5 | 15.6 | 20.2 | 18.9 | 14.3 | 28.1 | 32.6 | 39.1 |
| Interest income | 9.0 | 8.5 | 8.5 | 7.2 | 5.6 | 8.7 | | |
| Other income (expense), net [+] | -9.0 | -8.5 | -8.5 | -7.2 | -54.8 | -95.9 | -31.5 | -22.4 |
| Gain (loss) on debt retirement | | | | | 31.5 | | | |
| Pre-tax income | 451.4 | 411.6 | 366.9 | 368.7 | 272.6 | 270.8 | 325.6 | 260.5 |
| Income taxes | 87.5 | 81.7 | 86.0 | 89.5 | 70.1 | 75.2 | 108.3 | 133.0 |
| Tax rate | 19.4% | 19.8% | 23.4% | 24.3% | 25.7% | 27.8% | 33.3% | 51.1% |
| Earnings from continuing ops | 364.0 | 330.0 | 280.9 | 315.5 | 202.5 | 195.6 | 217.3 | 127.5 |
| Earnings from discontinued ops | | | | | 38.8 | | | |
| Net income | 364.0 | 574.9 | 319.3 | 315.5 | 241.2 | 195.6 | 217.3 | 127.5 |
| Net margin | 13.0% | 21.7% | 12.0% | 12.5% | 11.0% | 8.4% | 8.4% | 5.7% |
| |
| Basic EPS [+] | $3.29 | $2.93 | $2.42 | $2.71 | $1.72 | $1.65 | $1.77 | $1.04 |
| Growth | 12.3% | 20.8% | -10.6% | 57.1% | 4.5% | -7.1% | 71.4% | 148.1% |
| Diluted EPS [+] | $3.25 | $2.89 | $2.39 | $2.67 | $1.70 | $1.64 | $1.76 | $1.02 |
| Growth | 12.6% | 21.0% | -10.5% | 56.6% | 4.1% | -6.9% | 71.4% | 147.3% |
| |
| Dividends per share [+] | $1.07 | $0.96 | $0.77 | $0.67 | $0.61 | $0.55 | | |
| Growth | 11.9% | 25.0% | 15.0% | 9.8% | 10.9% | | | |
| |
| Shares outstanding (basic) [+] | 110.8 | 112.8 | 116.1 | 116.5 | 117.4 | 118.6 | 122.4 | 123.1 |
| Growth | -1.8% | -2.8% | -0.4% | -0.8% | -1.0% | -3.1% | -0.5% | -1.5% |
| Shares outstanding (diluted) [+] | 111.9 | 114.2 | 117.7 | 118.3 | 118.8 | 119.6 | 123.7 | 124.4 |
| Growth | -2.0% | -2.9% | -0.5% | -0.5% | -0.6% | -3.3% | -0.6% | -1.1% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|